Prudential Financial Inc Catalyst Pharmaceuticals, Inc. Transaction History

Prudential Financial Inc

$70 Billion
Q3 2024

A detailed history of Prudential Financial Inc transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Prudential Financial Inc holds 424,899 shares of CPRX stock, worth $9.22 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

424,899

Previous 195,059 117.83%

Holding current value

$9.22 Million

Previous $3.02 Million 179.58%

% of portfolio

0.01%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$15.19 - $21.35 $3.49 Million - $4.91 Million	229,840 Added 117.83%	424,899 $8.45 Million
Q2 2024 Aug 13, 2024	SELL	$14.68 - $16.92 $479,008 - $552,099	-32,630 Reduced 14.33%	195,059 $3.02 Million
Q1 2024 May 14, 2024	BUY	$13.18 - $17.11 $123,351 - $160,132	9,359 Added 4.29%	227,689 $3.63 Million
Q4 2023 Feb 13, 2024	SELL	$11.78 - $17.29 $4.21 Million - $6.17 Million	-357,110 Reduced 62.06%	218,330 $3.67 Million
Q3 2023 Nov 13, 2023	SELL	$11.69 - $15.02 $1.54 Million - $1.98 Million	-131,764 Reduced 18.63%	575,440 $6.73 Million
Q2 2023 Aug 11, 2023	SELL	$11.5 - $18.08 $430,157 - $676,282	-37,405 Reduced 5.02%	707,204 $9.5 Million
Q1 2023 May 12, 2023	SELL	$14.34 - $21.05 $1.04 Million - $1.52 Million	-72,281 Reduced 8.85%	744,609 $12.3 Million
Q4 2022 Feb 14, 2023	SELL	$12.25 - $19.5 $8.28 Million - $13.2 Million	-675,735 Reduced 45.27%	816,890 $0
Q3 2022 Nov 04, 2022	BUY	$7.06 - $15.52 $1.48 Million - $3.25 Million	209,580 Added 16.33%	1,492,625 $19.1 Million
Q2 2022 Aug 15, 2022	SELL	$6.23 - $8.57 $899,612 - $1.24 Million	-144,400 Reduced 10.12%	1,283,045 $8.99 Million
Q1 2022 May 13, 2022	BUY	$5.31 - $8.31 $925,240 - $1.45 Million	174,245 Added 13.9%	1,427,445 $11.8 Million
Q4 2021 Feb 14, 2022	SELL	$5.21 - $7.45 $2.1 Million - $3 Million	-402,552 Reduced 24.31%	1,253,200 $8.48 Million
Q3 2021 Nov 15, 2021	SELL	$4.85 - $6.04 $1.33 Million - $1.65 Million	-273,734 Reduced 14.19%	1,655,752 $8.78 Million
Q2 2021 Aug 16, 2021	SELL	$4.29 - $6.05 $3.52 Million - $4.96 Million	-819,693 Reduced 29.82%	1,929,486 $11.1 Million
Q1 2021 May 12, 2021	BUY	$3.45 - $4.69 $268,554 - $365,078	77,842 Added 2.91%	2,749,179 $12.7 Million
Q4 2020 Feb 16, 2021	BUY	$2.97 - $3.83 $663,795 - $856,005	223,500 Added 9.13%	2,671,337 $8.92 Million
Q3 2020 Nov 16, 2020	BUY	$2.97 - $5.08 $3.05 Million - $5.21 Million	1,026,088 Added 72.17%	2,447,837 $7.27 Million
Q2 2020 Aug 12, 2020	BUY	$3.48 - $5.05 $1.37 Million - $1.98 Million	392,281 Added 38.11%	1,421,749 $6.57 Million
Q1 2020 May 12, 2020	SELL	$2.61 - $5.21 $1.94 Million - $3.86 Million	-741,815 Reduced 41.88%	1,029,468 $3.96 Million
Q4 2019 Feb 11, 2020	BUY	$3.67 - $5.7 $2.63 Million - $4.09 Million	716,807 Added 67.98%	1,771,283 $6.64 Million
Q3 2019 Nov 13, 2019	BUY	$3.89 - $7.43 $2.42 Million - $4.62 Million	621,547 Added 143.57%	1,054,476 $5.6 Million
Q2 2019 Aug 08, 2019	BUY	$2.7 - $6.11 $902,299 - $2.04 Million	334,185 Added 338.44%	432,929 $0
Q1 2019 May 15, 2019	SELL	$2.11 - $5.33 $86,792 - $219,244	-41,134 Reduced 29.41%	98,744 $0
Q4 2018 Feb 07, 2019	SELL	$1.92 - $3.62 $154,608 - $291,500	-80,525 Reduced 36.54%	139,878 $268,000
Q3 2018 Nov 07, 2018	SELL	$2.81 - $3.78 $245,782 - $330,625	-87,467 Reduced 28.41%	220,403 $0
Q2 2018 Aug 13, 2018	BUY	$2.26 - $3.84 $303,292 - $515,328	134,200 Added 77.27%	307,870 $0
Q1 2018 May 04, 2018	BUY	$2.39 - $4.01 $127,865 - $214,535	53,500 Added 44.52%	173,670 $0
Q4 2017 Feb 13, 2018	BUY	$2.51 - $4.4 $301,626 - $528,748	120,170	120,170 $469,000

Others Institutions Holding CPRX

# of Institutions

325

Shares Held

94.2M

Call Options Held

19.1K

Put Options Held

51.1K

View Full List

About CATALYST PHARMACEUTICALS, INC.

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.23B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

More about CPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.

Account

Prudential Financial Inc Catalyst Pharmaceuticals, Inc. Transaction History